STAT+: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next
WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime…
Category: White House
Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in
WASHINGTON — The Supreme Court will this March hear arguments centered on the government’s role…
Supreme Court slates abortion pill case for March
WASHINGTON — The Supreme Court will hear arguments about access to the abortion medication mifepristone…
STAT+: FTC sues to block a proposed hospital deal in North Carolina
The federal government is suing to block a proposed hospital deal in North Carolina, alleging…
Bernie Sanders’ showdown with pharma CEOs is coming to a head
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
The White House has a pharmacy — and it’s been a mess, a new investigation found
There’s a pharmacy in the White House — or, at least, there’s a sign that…
Medicare Advantage update pushes Wall Street to reset expectations
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: FDA sets aggressive deadline for inspection overhaul
WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul…
STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
WASHINGTON — Negotiations to add extra health care policies to Congress’ stopgap funding bill fell…
STAT+: Biden changes will force health insurers to speed up and get more specific if they want to deny care
The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying…
STAT+: Copay coupons for some drugs must count toward deductibles, after Biden court move
WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending…
Health care negotiations on Capitol Hill are clear as mud
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
STAT+: Courts will decide the future of Medicare’s power to negotiate drug prices within months
WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare…
Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
WASHINGTON — He’s been called the “invisible” secretary. So far removed from the White House…
STAT+: HHS names inaugural chief competition officer
The Department of Health and Human Services will name Stacy Sanders as its new chief…
Biden’s FDA is letting Ron DeSantis import cheaper drugs from Canada. Who gets to take credit?
WASHINGTON — The Biden administration has approved Florida Gov. Ron DeSantis’ plan to import a…
At JPM, how much health policy talk should we expect?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
An ugly fight over care for the poor in Texas
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: 3 FDA staffers to watch in 2024
WASHINGTON — The Food and Drug Administration has a lot on its plate in 2024…
STAT+: Venture capital is still pouring into drug research despite Medicare price negotiation
WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s…
Pregnant cancer patients often have to terminate. Abortion pill restrictions could make that choice even harder
WASHINGTON — The patient had already made the agonizing decision to start chemotherapy to address…
What the new health counsels at FTC, DOJ, and HHS might do
Three major government agencies are adding new officials to investigate price-gouging in health care —…
Opinion: The Biden administration’s plan to use march-in rights to address drug prices would kill future world-changing innovations
The Bayh-Dole Act is widely credited with kickstarting a new era of American innovation involving the…
Supreme court will decide abortion pill access
WASHINGTON — The Supreme Court agreed Wednesday to take on whether Americans can access a…
STAT+: UnitedHealth executive to head health insurance group AHIP
WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next…
STAT+: Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials
A bipartisan group of senators is urging the Biden administration to beef up the amount…
STAT+: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
Will this be a half a loaf? After months of deliberation, the Biden administration on…
Diabetes ‘epidemic’ gets a Senate hearing
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: To lower drug prices, White House takes new aim at pharma patents
WASHINGTON — The White House is throwing its support behind a controversial authority that allows…
STAT+: Senate panel considers Medicare policy fixes to drug shortages
WASHINGTON — Members of the Senate Finance Committee took their first steps today toward using…
STAT+: Cancer drug shortages won’t get better under Biden’s latest plan
WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production…
STAT+: Official: FDA needs staff influx to meet gene therapy needs
WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its…
STAT+: Senate Republicans throw cold water on so-called site-neutral hospital pay cuts
WASHINGTON — On its face, a minor policy to make sure Medicare pays hospitals the…
CDC Director Mandy Cohen unscathed in her first congressional testimony
WASHINGTON — House Republicans sought Thursday to hammer the Centers for Disease Control and Prevention’s…
STAT+: Biden defends Trump-era drug pricing rule on copay accumulators
WASHINGTON — The Biden administration is appealing a court ruling against a Trump-era regulation that…
STAT+: FDA chief scientist to replace Woodcock
WASHINGTON — The Food and Drug Administration’s chief scientist will replace retiring Janet Woodcock as principal…
STAT+: White House official dings Bristol-Myers Squibb for fighting off generic competition
WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a…
STAT+: Scott Gottlieb, Trump FDA chief, questions whether there’s a Republican philosophy on health care
WASHINGTON — One of the Republican party’s most prominent health care thinkers doesn’t know what…
STAT+: Biden invokes Cold War-era law to stem drug shortages
WASHINGTON — President Biden is using a Cold War-era law to stem drug shortages by…
STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue
WASHINGTON — It took nearly three weeks for a maker of eye drops to recall…
STAT+: Biden appoints Vanderbilt oncologist to head National Cancer Institute
WASHINGTON — President Biden on Friday said he plans to appoint cancer researcher and doctor…
STAT+: FDA’s latest reorganization puts a new emphasis on its investigations
WASHINGTON — There’s about to be a new acronym in town. The Food and Drug…
STAT+: House moves to limit so-called gain-of-function research
WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious…
STAT+: To get things done fast at FDA: ‘Don’t tell anybody,’ cancer chief says
WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for…